Vaccines and Influenza Drugs Market to Grow 10.24% CAGR by 2022 Says a new Research at ReportsnReports

Thursday, July 20, 2017 Drug News
Email Print This Page Comment bookmark
Font : A-A+

PUNE, India, July 20, 2017 /PRNewswire/ --

Influenza Drugs and Vaccines Market - By Drugs (Zanamivir, Oseltamivir

Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent) - Analysis By Region, By Country: Opportunities and Forecast (2016-2021) report has covered and analysed the potential of Global Influenza Market and provides statistics and information on market
size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global influenza market. Additionally, the report also highlights key development and new drugs launched by various companies across the globe.

Browse 78 Tables and Figures, 10 Companies Profiles, spread across 164 pages @

Global Influenza Drugs and Vaccines Market is projected to display a steady growth rate represented by a CAGR of 10.24% during 2017 - 2022, chiefly driven by increasing spending over various immunization programmes. Rising awareness in relation to influenza virus, surging investment by companies in R&D and increasing number of immunization programmes organized by the government have been some of the factors backing the growth of Global Influenza Market.

Company Profile Analysis covered in this Report - Falvogen, Gilead Science and Bio Cryst, GlaxoSmithKline, Sanofi Pasteur, Inc., CSL Limited, Astrazeneca, Protein Sciences Corporation, Serum Institute of India Pvt. Ltd., Emergent Biosolutions, Emergent Biosolutions, BioCryst Pharmaceuticals.Inc., and Alvogen. Order a copy of Report @

Scope of the Report: Global Influenza Market; Regional Markets - North America, Europe, APAC, RoW; Country Analysis - US, Canada, UK, Germany, France, Japan, China, India; 

(Actual Period: 2012-2016E, Forecast Period: 2017-2022) By Segment Type: Influenza Vaccine Market, Influenza Drugs Market By Vaccine Type: Trivalent, Quadrivalent By Drug Type: Zanamivi, Oseltamivir Phosphate, Peramivir

Table of Contents 

Influenza Market: An Introduction Global Influenza Market Overview Global Influenza Market: Product Analysis Global Influenza Vaccines & Drugs - Pipeline Analysis Global Influenza Market, Breakdown By Region 

Other related report Global Lysine Market by Manufacturers, Countries, Type and Application, Forecast to 2022 is a professional and in-depth study on the current state of the Lysine industry. The Lysine market analysis is provided for the international market including development history, competitive landscape analysis, and major regions development status. Report provides Introduction, product scope, market overview, market opportunities, market risk, and market driving force. This report focuses on the Lysine in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. This report covers market segment by manufacturers: CJ(KR), Ajinomoto(JP), ADM(US), Evonik(DE), GLOBAL Bio-Chem(CN), Meihua(CN), COFCO(CN), East Hope(CN), Juneng Golden Corn(CN), and Chengfu Group(CN).

About Us: is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports. We provide 24/7 online and offline support to our customers.

Contact: Ritesh Tiwari 2nd Floor, Metropole, Next to Inox Theatre, Bund Garden Road, Pune - 411001 Maharashtra, India. +1-8883915441

Connect With Us On: 

RSS Link:


SOURCE ReportsnReports

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store